Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Patients With PBC (Q113895753)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Patients With PBC |
clinical trial |
Statements
A Phase 2, Double-Blind, Randomized, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Obeticholic Acid Administered in Combination With Bezafibrate in Subjects With Primary Biliary Cholangitis Who Had an Inadequate Response or Who Were Unable to Tolerate Ursodeoxycholic Acid (English)
0 references
2 October 2019
0 references
July 2022
0 references
75
0 references
18 year
0 references